Clinical trialNCT02536508CompletedPhase 3Interventional

Study to Assess the Safety and Tolerability of PT010, PT009 and PT003 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

SponsorPearl Therapeutics, Inc.Enrollment627COPD

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Colin Reisner
Pearl Therapeutics
Study Director
clinicaltrials.gov ↗
Paul Dorinsky, MD
Pearl Therapeutics
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

64 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Dothan, Alabama, United States
Research Site
Jasper, Alabama, United States
Research Site
Peoria, Arizona, United States
Research Site
Phoenix, Arizona, United States
Research Site
Fullerton, California, United States
Research Site
Gold River, California, United States
Research Site
Poway, California, United States
Research Site
Rolling Hills Estates, California, United States
Research Site
Sacramento, California, United States
Research Site
Clearwater, Florida, United States
Research Site
Miami, Florida, United States
Research Site
Ormond Beach, Florida, United States
Research Site
Pensacola, Florida, United States
Research Site
Tamarac, Florida, United States
Research Site
Tampa, Florida, United States
Research Site
Winter Park, Florida, United States
Research Site
Dacula, Georgia, United States
Research Site
Norcross, Georgia, United States
Research Site
Rincon, Georgia, United States
Research Site
Edina, Minnesota, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Minneapolis, Minnesota, United States
Research Site
Woodbury, Minnesota, United States
Research Site
Saint Charles, Missouri, United States
Research Site
St Louis, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Reno, Nevada, United States
Research Site
Albuquerque, New Mexico, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Gastonia, North Carolina, United States
Research Site
Greensboro, North Carolina, United States
Research Site
Hendersonville, North Carolina, United States
Research Site
Mooresville, North Carolina, United States
Research Site
Wilmington, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Cincinnati, Ohio, United States
Research Site
Columbus, Ohio, United States
Research Site
Columbus, Ohio, United States

24 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 Aug 2015
Primary completion: 12 Sept 2017
Completion: 12 Sept 2017
Last update posted: 26 Feb 2021
Registered enrollment: 627
Registry id: NCT02536508

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.